These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 39087914)

  • 21. Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?
    Sutherland GT; Halliday GM; Silburn PA; Mastaglia FL; Rowe DB; Boyle RS; O'Sullivan JD; Ly T; Wilton SD; Mellick GD
    Mov Disord; 2009 Apr; 24(6):833-8. PubMed ID: 19224617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease.
    Nishioka K; Kefi M; Jasinska-Myga B; Wider C; Vilariño-Güell C; Ross OA; Heckman MG; Middleton LT; Ishihara-Paul L; Gibson RA; Amouri R; Ben Yahmed S; Ben Sassi S; Zouari M; El Euch G; Farrer MJ; Hentati F
    J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):391-5. PubMed ID: 19726410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
    Healy DG; Falchi M; O'Sullivan SS; Bonifati V; Durr A; Bressman S; Brice A; Aasly J; Zabetian CP; Goldwurm S; Ferreira JJ; Tolosa E; Kay DM; Klein C; Williams DR; Marras C; Lang AE; Wszolek ZK; Berciano J; Schapira AH; Lynch T; Bhatia KP; Gasser T; Lees AJ; Wood NW;
    Lancet Neurol; 2008 Jul; 7(7):583-90. PubMed ID: 18539534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDSGene: Closing Data Gaps in Genotype-Phenotype Correlations of Monogenic Parkinson's Disease.
    Klein C; Hattori N; Marras C
    J Parkinsons Dis; 2018; 8(s1):S25-S30. PubMed ID: 30584170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic testing for Parkinson's disease in clinical practice.
    Gasser T
    J Neural Transm (Vienna); 2023 Jun; 130(6):777-782. PubMed ID: 36929227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pooled-DNA target sequencing of Parkinson genes reveals novel phenotypic associations in Spanish population.
    Diez-Fairen M; Benitez BA; Ortega-Cubero S; Lorenzo-Betancor O; Cruchaga C; Lorenzo E; Samaranch L; Carcel M; Obeso JA; Rodriguez-Oroz MC; Aguilar M; Coria F; Pastor MA; Pastor P
    Neurobiol Aging; 2018 Oct; 70():325.e1-325.e5. PubMed ID: 29887346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Inducible Luminescent System to Explore Parkinson's Disease-Associated Genes.
    Gandy A; Maussion G; Al-Habyan S; Nicouleau M; You Z; Chen CX; Abdian N; Aprahamian N; Krahn AI; Larocque L; Durcan TM; Deneault E
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age at Onset of Parkinson's Disease Among Ashkenazi Jewish Patients: Contribution of Environmental Factors, LRRK2 p.G2019S and GBA p.N370S Mutations.
    Yahalom G; Rigbi A; Israeli-Korn S; Krohn L; Rudakou U; Ruskey JA; Benshimol L; Tsafnat T; Gan-Or Z; Hassin-Baer S; Greenbaum L
    J Parkinsons Dis; 2020; 10(3):1123-1132. PubMed ID: 32310186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and molecular genetic findings of hereditary Parkinson's patients from Turkey.
    Emekli I; Tepgeç F; Samancı B; Toksoy G; Hasanoğulları Kına G; Tüfekçioğlu Z; Başaran S; Bilgiç B; Gürvit IH; Emre M; Uyguner ZO; Hanagasi HA
    Parkinsonism Relat Disord; 2021 Dec; 93():35-39. PubMed ID: 34781237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical genetics of Parkinson's disease and related disorders.
    Wider C; Wszolek ZK
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin.
    Senkevich K; Rudakou U; Gan-Or Z
    Neuropharmacology; 2022 Jan; 202():108822. PubMed ID: 34626666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson's disease gene rearrangements.
    Scarciolla O; Brancati F; Valente EM; Ferraris A; De Angelis MV; Valbonesi S; Garavaglia B; Uncini A; Palka G; Stuppia L; Dallapiccola B
    Mov Disord; 2007 Nov; 22(15):2274-8. PubMed ID: 17914726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson's patients and genotype-phenotype correlations.
    Erer S; Egeli U; Zarifoglu M; Tezcan G; Cecener G; Tunca B; Ak S; Demirdogen E; Kenangil G; Kaleagası H; Dogu O; Saka E; Elibol B
    Clin Neurol Neurosurg; 2016 Sep; 148():147-53. PubMed ID: 27455133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precision medicine in Parkinson's disease patients with LRRK2 and GBA risk variants - Let's get even more personal.
    von Linstow CU; Gan-Or Z; Brundin P
    Transl Neurodegener; 2020 Oct; 9(1):39. PubMed ID: 33066808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A DNA resequencing array for genes involved in Parkinson's disease.
    Wilkins EJ; Rubio JP; Kotschet KE; Cowie TF; Boon WC; O'Hely M; Burfoot R; Wang W; Sue CM; Speed TP; Stankovitch J; Horne MK
    Parkinsonism Relat Disord; 2012 May; 18(4):386-90. PubMed ID: 22243833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of p.G2019S Mutation in the
    Usenko TS; Timofeeva A; Beletskaia M; Basharova K; Baydakova G; Bezrukova A; Grunina M; Emelyanov A; Miliukhina I; Zakharova E; Pchelina S
    J Integr Neurosci; 2024 Jan; 23(1):16. PubMed ID: 38287861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.
    Kilarski LL; Pearson JP; Newsway V; Majounie E; Knipe MD; Misbahuddin A; Chinnery PF; Burn DJ; Clarke CE; Marion MH; Lewthwaite AJ; Nicholl DJ; Wood NW; Morrison KE; Williams-Gray CH; Evans JR; Sawcer SJ; Barker RA; Wickremaratchi MM; Ben-Shlomo Y; Williams NM; Morris HR
    Mov Disord; 2012 Oct; 27(12):1522-9. PubMed ID: 22956510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PRKN, DJ-1, and PINK1 screening identifies novel splice site mutation in PRKN and two novel DJ-1 mutations.
    Ghazavi F; Fazlali Z; Banihosseini SS; Hosseini SR; Kazemi MH; Shojaee S; Parsa K; Sadeghi H; Sina F; Rohani M; Shahidi GA; Ghaemi N; Ronaghi M; Elahi E
    Mov Disord; 2011 Jan; 26(1):80-9. PubMed ID: 21322020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.
    Gustavsson EK; Follett J; Trinh J; Barodia SK; Real R; Liu Z; Grant-Peters M; Fox JD; Appel-Cresswell S; Stoessl AJ; Rajput A; Rajput AH; Auer R; Tilney R; Sturm M; Haack TB; Lesage S; Tesson C; Brice A; Vilariño-Güell C; Ryten M; Goldberg MS; West AB; Hu MT; Morris HR; Sharma M; Gan-Or Z; Samanci B; Lis P; Periñan MT; Amouri R; Ben Sassi S; Hentati F; ; Tonelli F; Alessi DR; Farrer MJ
    Lancet Neurol; 2024 Jun; 23(6):603-614. PubMed ID: 38614108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.